Patient info

J05AP51 sofosbuvir and ledipasvir

ATC group of level 5 – chemical substance · in plain English: medicines against viruses, e.g. HIV or hepatitis

This site has the patient leaflet or the SPC of 4 medicines in this group.

Place in the ATC classification

  1. J Antiinfectives for systemic use 1,393 medicines
    1. J05 Antivirals for systemic use 392 medicines
      1. J05A Direct acting antivirals 392 medicines
        1. J05AP Antivirals for treatment of HCV infections 25 medicines
          1. J05AP51 sofosbuvir and ledipasvir 4 medicines

Active substances in the group

Medicines

MedicineLegal category
Harvoni 33.75 mg / 150 mg coated granules in sachet no longer supplied –
Harvoni 45 mg / 200 mg coated granules in sachet SPC no longer supplied –
Harvoni 90 mg / 400 mg film-coated tablets SPC Prescription only (POM)
Ledipasvir/sofosbuvir Gilead 45 mg/200 mg film-coated tablets no longer supplied –

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group J05AP51

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.